On the back of the headline studies Temprano, START, and new data from HPTN 052, WHO recently announced the 'treat-all' policy: everyone diagnosed with HIV should start antiretroviral therapy (ART), regardless of their immunological ...
Dec 2, 2015
0
0
For many years, clinicians debated the best time to start antiretroviral therapy (ART) for HIV infection, with some worrying that the risks of treatment in terms of drug toxicities could outweigh the benefits of controlling ...
Dec 1, 2015
0
0
A new clinical trial will test whether it is possible to destroy hidden reservoirs of HIV virus that are a key obstacle to curing the disease.
Dec 1, 2015
0
2
Improvements in availability of antiretroviral therapy (ART) for HIV in South Africa over the past decade coincide with an increased gap in female versus male life expectancy, according to a study published in PLOS Medicine ...
Nov 24, 2015
0
0
The UN on Tuesday urged countries to "break the AIDS epidemic" by doubling the number of people receiving HIV treatment within the next five years.
Nov 24, 2015
0
0
Antiretroviral drugs can suppress HIV for years, but a residual inflammatory imbalance contributes to health problems in infected individuals who are infected with the virus. A novel combination treatment aimed at repairing ...
Nov 9, 2015
0
8
Current antiretroviral therapy can keep HIV in check and prevent AIDS in the vast majority of treated patients. However, as it is unable to eliminate viral reservoirs and cure the infection, patients need to stay on the life-long ...
Nov 5, 2015
0
14
After peaking in 2007, AIDS mortality in South Africa has decreased with the widespread introduction of effective antiretroviral therapy, according to updated estimates published in AIDS, official journal of the International ...
Oct 29, 2015
1
5
Scientists at the National Institutes of Health (NIH) have created a protein that awakens resting immune cells infected with HIV and facilitates their destruction in laboratory studies. The protein potentially could contribute ...
Oct 20, 2015
0
2657
Viral persistence and chronic inflammation are two key features of HIV-positive patients on antiretroviral therapy (ART). A study published on September 24th in PLOS Pathogens reports results from macaques and humans that ...
Sep 24, 2015
0
23
